KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

BACKGROUND: KRAS codons 12 and 13 mutations predict resistance to anti-EGFR monoclonal antibodies (moAbs) in metastatic colorectal cancer. Also, BRAF V600E mutation has been associated with resistance. Additional KRAS mutations are described in CRC. METHODS: We investigated the role of KRAS codons 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Loupakis, F, Ruzzo, A, Cremolini, C, Vincenzi, B, Salvatore, L, Santini, D, Masi, G, Stasi, I, Canestrari, E, Rulli, E, Floriani, I, Bencardino, K, Galluccio, N, Catalano, V, Tonini, G, Magnani, M, Fontanini, G, Basolo, F, Falcone, A, Graziano, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736831/
https://www.ncbi.nlm.nih.gov/pubmed/19603018
http://dx.doi.org/10.1038/sj.bjc.6605177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736831/
https://www.ncbi.nlm.nih.gov/pubmed/19603018
http://dx.doi.org/10.1038/sj.bjc.6605177

Ejemplares similares